NVDA 227.38 ▲2.30%GOOGL 354.97 ▲1.55%MSFT 501.61 ▲1.59%AMD 615.52 ▲9.95%INTC 121.78 ▲12.14%TSMC 445.14 ▲2.41%AMZN 258.45 ▲1.87%META 741.25 ▲11.34%AAPL 338.98 ▲0.85%PLTR 183.09 ▲3.07%
Markets at last close

Health

Clinical AI access still depends on credentials and institutions in 2026

·1 min read

A July 2026 pricing reference compares 9 clinical AI and decision support tools by cost, verification requirements, and regional availability. Published individual prices are concentrated among a few products: UpToDate starts at $579/yr, Pro Plus with Expert AI is $699/yr, the trainee tier is $219/yr, and AMBOSS costs $149/yr for students and $259/yr for practitioners.

Free access often comes with limits. OpenEvidence is free but requires a U.S. NPI number and withdrew from the EU and UK in April 2026. Doximity Ask is free but tied to U.S. clinician verification, while BMJ Best Practice is free for eligible NHS staff in England, Scotland, and Wales through national funding.

Only EvidenceMD and MDCalc are described as free options without a geographic or credential gate. EvidenceMD is free to start worldwide in 30 languages, while MDCalc remains a free library of validated calculators rather than a generative AI tool. ClinicalKey AI and DynaMedex publish no individual retail price and are sold mainly through hospitals, universities, libraries, and other institutions.

Originally reported by evidencemd.aiRead the source →
Related coverage